Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-04-04 @ 5:37 AM
Study NCT ID:
NCT02014467
Status:
COMPLETED
Last Update Posted:
2016-10-31
First Post:
2013-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Denosumab China Phase III Study
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-12
First Submit QC Date:
None
Study First Post Date:
2013-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-31
Results First Submit QC Date:
None
Results First Post Date:
2016-10-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-08
Last Update Post Date:
2016-10-31
Last Update Post Date Type:
ESTIMATED